Most Recent

image: Reducing Gene Therapy-Related Risk

Reducing Gene Therapy-Related Risk

By | January 22, 2015

In a mouse model of a rare disease, scientists have figured out how to reduce the elevated cancer risk tied to a gene therapy treatment.

0 Comments

image: GMO “Kill Switches”

GMO “Kill Switches”

By | January 21, 2015

Scientists design bacteria reliant upon synthetic amino acids to contain genetically modified organisms.

6 Comments

image: Fraction of SNPs Can Affect Fitness

Fraction of SNPs Can Affect Fitness

By | January 21, 2015

A point mutation analysis of the entire human genome finds that alterations to as many as 7.5 percent of nucleotides may have contributed to humans’ evolutionary split from chimpanzees.

1 Comment

image: Tracking Tuberculosis Over Time

Tracking Tuberculosis Over Time

By | January 19, 2015

Genomic analysis of a multidrug-resistant lineage pinpoints historical correlations with human events.

0 Comments

image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Genome Digest

Genome Digest

By | January 12, 2015

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: Mitochondrial Enzyme Detailed

Mitochondrial Enzyme Detailed

By | January 9, 2015

Researchers reveal clues regarding how an ancient mitochondrial enzyme helps maintain healthy cells across the tree of life.

0 Comments

image: Corn Chronicle

Corn Chronicle

By | January 8, 2015

A genetic analysis of ancient and modern maize clarifies the crop’s checkered domestication history.

0 Comments

image: 23andMe, Genentech Partner on Parkinson’s

23andMe, Genentech Partner on Parkinson’s

By | January 7, 2015

Firms enter a multi-year deal for the analysis of whole-genome sequence data, with an eye toward drug discovery for Parkinson’s disease.

0 Comments

image: Custom Creatures?

Custom Creatures?

By | January 6, 2015

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS